Characteristics of Suspected COVID-19 Discharged Emergency Department Patients Who Returned During the First Wave.
Journal
The western journal of emergency medicine
ISSN: 1936-9018
Titre abrégé: West J Emerg Med
Pays: United States
ID NLM: 101476450
Informations de publication
Date de publication:
03 Apr 2023
03 Apr 2023
Historique:
received:
31
08
2023
accepted:
24
01
2023
medline:
8
6
2023
pubmed:
6
6
2023
entrez:
6
6
2023
Statut:
epublish
Résumé
Limited information exists on patients with suspected coronavirus disease 2019 (COVID-19) who return to the emergency department (ED) during the first wave. In this study we aimed to identify predictors of ED return within 72 hours for patients with suspected COVID-19. Incorporating data from 14 EDs within an integrated healthcare network in the New York metropolitan region from March 2-April 27, 2020, we analyzed this data on predictors for a return ED visit-including demographics, comorbidities, vital signs, and laboratory results. In total, 18,599 patients were included in the study. The median age was 46 years old [interquartile range 34-58]), 50.74% were female, and 49.26% were male. Overall, 532 (2.86%) returned to the ED within 72 hours, and 95.49% were admitted at the return visit. Of those tested for COVID-19, 59.24% (4704/7941) tested positive. Patients with chief complaints of "fever" or "flu" or a history of diabetes or renal disease were more likely to return at 72 hours. Risk of return increased with persistently abnormal temperature (odds ratio [OR] 2.43, 95% CI 1.8-3.2), respiratory rate (2.17, 95% CI 1.6-3.0), and chest radiograph (OR 2.54, 95% CI 2.0-3.2). Abnormally high neutrophil counts, low platelet counts, high bicarbonate values, and high aspartate aminotransferase levels were associated with a higher rate of return. Risk of return decreased when discharged on antibiotics (OR 0.12, 95% CI 0.0-0.3) or corticosteroids (OR 0.12, 95% CI 0.0-0.9). The low overall return rate of patients during the first COVID-19 wave indicates that physicians' clinical decision-making successfully identified those acceptable for discharge.
Identifiants
pubmed: 37278789
pii: westjem.58717
doi: 10.5811/westjem.58717
pmc: PMC10284524
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
405-415Références
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Am J Emerg Med. 2021 Jul;45:185-191
pubmed: 33046303
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Intensive Care Med. 2020 Jun;46(6):1294-1297
pubmed: 32253449
Acad Emerg Med. 2020 Oct;27(10):1039-1042
pubmed: 32853423
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jun 24;48(6):450-455
pubmed: 32120458
West J Emerg Med. 2020 Sep 24;21(6):5-14
pubmed: 33052820
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
J Am Coll Emerg Physicians Open. 2020 Aug 17;1(6):1380-1385
pubmed: 32838391
Ann Emerg Med. 2020 Oct;76(4):405-412
pubmed: 32563600
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Crit Care. 2020 Mar 18;24(1):108
pubmed: 32188484
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Ann Transl Med. 2020 May;8(9):576
pubmed: 32566603
Clin Infect Dis. 2020 Jul 28;71(15):769-777
pubmed: 32176772
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7861-7868
pubmed: 32744714
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Infect. 2020 Apr;80(4):401-406
pubmed: 32112886
West J Emerg Med. 2021 Nov 05;22(6):1257-1261
pubmed: 34787548
Clin Infect Dis. 2021 Dec 6;73(11):e4208-e4213
pubmed: 32173725